Miyagishima K, Qiao F, Stasheff S, Nadal-Nicolas F
Vision (Basel). 2024; 8(2).
PMID: 38804352
PMC: 11130890.
DOI: 10.3390/vision8020031.
Bianchi F, Cocilovo F, Ruggiero A, Tamburrini G
Adv Tech Stand Neurosurg. 2023; 48:123-137.
PMID: 37770684
DOI: 10.1007/978-3-031-36785-4_6.
Tang Y, Gutmann D
Cancer Manag Res. 2023; 15:667-681.
PMID: 37465080
PMC: 10351533.
DOI: 10.2147/CMAR.S362678.
Yousefi O, Azami P, Sabahi M, Dabecco R, Adada B, Borghei-Razavi H
Cancers (Basel). 2022; 14(19).
PMID: 36230704
PMC: 9563939.
DOI: 10.3390/cancers14194781.
Yilmaz E, Emengen A, Ceylan E, Cabuk B, Anik I, Ceylan S
Childs Nerv Syst. 2022; 38(11):2071-2082.
PMID: 36087131
DOI: 10.1007/s00381-022-05665-7.
Visual Outcome for Children with Optic Pathway Gliomas Treated with Systemic Chemotherapy.
Mohammad M, Alrawashdeh H, Mehyar M, Amayiri N, Abu Laban D, AlNawaiseh I
Clin Ophthalmol. 2022; 16:2933-2942.
PMID: 36071723
PMC: 9444037.
DOI: 10.2147/OPTH.S374959.
Epidemiology and Survival of Patients With Optic Pathway Gliomas: A Population-Based Analysis.
Liu H, Chen Y, Qin X, Jin Z, Jiang Y, Wang Y
Front Oncol. 2022; 12:789856.
PMID: 35223473
PMC: 8874351.
DOI: 10.3389/fonc.2022.789856.
Optic Nerve Gliomas.
Wladis E, Adamo M, Weintraub L
J Neurol Surg B Skull Base. 2021; 82(1):91-95.
PMID: 33777621
PMC: 7987392.
DOI: 10.1055/s-0040-1722634.
The Visual Acuity Outcome and Relevant Factors Affecting Visual Improvement in Pediatric Sporadic Chiasmatic-Hypothalamic Glioma Patients Who Received Surgery.
Liao C, Zhang H, Liu Z, Han Z, Li C, Gong J
Front Neurol. 2020; 11:766.
PMID: 32973646
PMC: 7466562.
DOI: 10.3389/fneur.2020.00766.
Predicting pediatric optic pathway glioma progression using advanced magnetic resonance image analysis and machine learning.
Pisapia J, Akbari H, Rozycki M, Thawani J, Storm P, Avery R
Neurooncol Adv. 2020; 2(1):vdaa090.
PMID: 32885166
PMC: 7455885.
DOI: 10.1093/noajnl/vdaa090.
Visual function tests including the role of optical coherence tomography in neurofibromatosis 1.
Mezad-Koursh D, Zipori A, Zur D, Degabli L, Ben-Dov M, Klein A
Childs Nerv Syst. 2020; 36(10):2363-2375.
PMID: 32749524
DOI: 10.1007/s00381-020-04706-3.
Neurofibromatosis 1-associated optic pathway gliomas.
Shofty B, Ben Sira L, Constantini S
Childs Nerv Syst. 2020; 36(10):2351-2361.
PMID: 32524182
DOI: 10.1007/s00381-020-04697-1.
Long-term visual acuity outcomes after radiation therapy for sporadic optic pathway glioma.
Acharya S, Quesada S, Coca K, Richardson C, Hoehn M, Chiang J
J Neurooncol. 2019; 144(3):603-610.
PMID: 31414376
DOI: 10.1007/s11060-019-03264-2.
Endoscopic endonasal skull base surgery for pediatric brain tumors.
Kim Y, Lee J, Phi J, Wang K, Kim S
Childs Nerv Syst. 2019; 35(11):2081-2090.
PMID: 31377913
DOI: 10.1007/s00381-019-04335-5.
Current treatment of optic nerve gliomas.
Farazdaghi M, Katowitz W, Avery R
Curr Opin Ophthalmol. 2019; 30(5):356-363.
PMID: 31246635
PMC: 7410088.
DOI: 10.1097/ICU.0000000000000587.
Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?.
Maloney E, Stanescu A, Perez F, Iyer R, Otto R, Leary S
Pediatr Radiol. 2018; 48(10):1472-1484.
PMID: 29789890
DOI: 10.1007/s00247-018-4154-4.
Pediatric Glioma at the Optic Pathway and Thalamus.
Park E, Park J, Ra Y
J Korean Neurosurg Soc. 2018; 61(3):352-362.
PMID: 29742884
PMC: 5957311.
DOI: 10.3340/jkns.2018.0040.
Optic Pathway Gliomas in Neurofibromatosis Type 1.
Campen C, Gutmann D
J Child Neurol. 2017; 33(1):73-81.
PMID: 29246098
PMC: 5739070.
DOI: 10.1177/0883073817739509.
Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
Wan M, Ullrich N, Manley P, Kieran M, Goumnerova L, Heidary G
J Neurooncol. 2016; 129(1):173-8.
PMID: 27311725
DOI: 10.1007/s11060-016-2163-4.
Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?.
Aquilina K, Daniels D, Spoudeas H, Phipps K, Gan H, Boop F
Childs Nerv Syst. 2015; 31(11):2041-9.
PMID: 26277358
DOI: 10.1007/s00381-015-2855-7.